Prognostic and Predictive Biomarkers in Patients with Locally Advanced Rectal Cancer (LARC) Treated with Preoperative Chemoradiotherapy

Prognostic and Predictive Biomarkers in Patients with Locally Advanced Rectal Cancer (LARC) Treated with Preoperative Chemoradiotherapy

Neoadjuvant chemoradiotherapy (CRT) is one of the standards of care in locally advanced rectal cancer (LARC). This retrospective study examines clinical, analytical, and pathological parameters collected from 77 patients with locally advanced (cT3-4 or cN+) rectal carcinoma diagnosed between 2007 an...

Full description

Bibliographic Details
Main Authors:	Alfonso Martín-Carnicero, Enrique Ramalle-Gomara, Susana Rubio-Mediavilla, Martina Alonso-Lago, Miriam Zorrilla-Larraga, Isabel Manrique-Abós, María E. de las Heras-Dueña, Ignacio M. Larrayoz, Alfredo Martínez
Format:	Article
Language:	English
Published:	MDPI AG 2022-10-01
Series:	Journal of Clinical Medicine
Subjects:	locally advanced rectal cancer neoadjuvant chemoradiotherapy prognostic biomarkers predictive biomarkers hemoglobin lymphocyte/monocyte ratio
Online Access:	https://www.mdpi.com/2077-0383/11/20/6091

Similar Items

C-Reactive Protein as Predictive Biomarker for Response to Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: A Retrospective Study
by: Fátima Aires, et al.
Published: (2022-01-01)

2-CONSERVATIVE TREATMENT OF RECTAL ADENOCARCINOMA AFTER NEOADJUVANT CHEMORADIOTHERAPY, IS IT ACCEPTABLE?
by: Majeed H Alwan
Published: (2009-06-01)

BIOLOGICAL MARKERS OF RECTAL CANCER NEOADJUVANT CHEMORADIOTHERAPY EFFICACY
by: M. Yu. Fedyanin, et al.
Published: (2015-02-01)

Impact of Tumor Regression Grade as a Major Prognostic Factor in Locally Advanced Rectal Cancer after Neoadjuvant Chemoradiotherapy: A Proposal for a Modified Staging System
by: Changhoon Song, et al.
Published: (2018-09-01)

Pre-Existing Tumoral B Cell Infiltration and Impaired Genome Maintenance Correlate with Response to Chemoradiotherapy in Locally Advanced Rectal Cancer
by: Juan M. Sendoya, et al.
Published: (2020-08-01)

Neoadjuvant chemoradiotherapy in combined treatment of patients with rectal cancer
by: N. A. Maistrenko, et al.
Published: (2017-08-01)

Exploring novel genetic and hematological predictors of response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer
by: Mladen Marinkovic, et al.
Published: (2023-08-01)

The potential predictive value of DEK expression for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer
by: J. Martinez-Useros, et al.
Published: (2018-02-01)

Performance and Dimensionality of Pretreatment MRI Radiomics in Rectal Carcinoma Chemoradiotherapy Prediction
by: Mladen Marinkovic, et al.
Published: (2024-01-01)

Impact of glucocorticoids on the efficacy of neoadjuvant chemoradiotherapy and survival of patients with locally advanced rectal cancer: a retrospective study
by: Xiaoxue Huang, et al.
Published: (2023-03-01)

Efficacy of modified neoadjuvant chemoradiotherapy in locally advanced rectal cancer: A single institution experience in Taiwan
by: Yi-Ying Wu, et al.
Published: (2014-01-01)

Laparoscopic total pelvic exenteration after neoadjuvant chemoradiotherapy for locally advanced rectal cancer
by: Chu-Ying Wu, et al.
Published: (2022-11-01)

Nomogram Predicting Overall Survival of Resected Locally Advanced Rectal Cancer Patients with Neoadjuvant Chemoradiotherapy
by: Song J, et al.
Published: (2020-08-01)

Genomic alterations in rectal tumors and response to neoadjuvant chemoradiotherapy: an exploratory study
by: Molinari Chiara, et al.
Published: (2011-11-01)

Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer
by: Huaqin Lin, et al.
Published: (2021-05-01)

Surgical treatment following neoadjuvant chemoradiotherapy in locally advanced rectal cancer
by: Ming‐Yii Huang, et al.
Published: (2020-03-01)

Development and Validation of a Predictive Model for Toxicity of Neoadjuvant Chemoradiotherapy in Rectal Cancer in the CAO/ARO/AIO-04 Phase III Trial
by: Markus Diefenhardt, et al.
Published: (2022-09-01)

Characterization of the tumor microenvironment and identification of spatially predictive biomarkers associated with beneficial neoadjuvant chemoradiotherapy in locally advanced rectal cancer
by: Shifen Zhang, et al.
Published: (2023-11-01)

Validation of Gene Expression-Based Predictive Biomarkers for Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
by: Tomoyuki Momma, et al.
Published: (2021-09-01)

Machine learning-based multiparametric MRI radiomics for predicting poor responders after neoadjuvant chemoradiotherapy in rectal Cancer patients
by: Jia Wang, et al.
Published: (2022-04-01)

Accuracy of high-resolution rectal magnetic resonance imaging re-staging with histopathology in locally advanced rectal cancer after neoadjuvant chemoradiotherapy
by: Supparerk Laohawiriyakamol, et al.
Published: (2021-01-01)

Pretreatment blood biomarkers combined with magnetic resonance imaging predict responses to neoadjuvant chemoradiotherapy in locally advanced rectal cancer
by: Xinyu Shi, et al.
Published: (2022-08-01)

MRI-based pre-Radiomics and delta-Radiomics models accurately predict the post-treatment response of rectal adenocarcinoma to neoadjuvant chemoradiotherapy
by: Likun Wang, et al.
Published: (2023-02-01)

A Nine-Gene Signature for Predicting the Response to Preoperative Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer
by: In Ja Park, et al.
Published: (2020-03-01)

An Immune-Related Gene Signature for Predicting Neoadjuvant Chemoradiotherapy Efficacy in Rectal Carcinoma
by: Liwen Qian, et al.
Published: (2022-05-01)

Characterization of the gene signature correlated with favorable response to chemoradiotherapy in rectal cancer: A hypothesis‐generating study
by: Seung Hyuck Jeon, et al.
Published: (2023-04-01)

Body composition parameters combined with blood biomarkers and magnetic resonance imaging predict responses to neoadjuvant chemoradiotherapy in locally advanced rectal cancer
by: Jianguo Yang, et al.
Published: (2023-11-01)

Clinical benefits of oral capecitabine over intravenous 5-fluorouracyl regimen in case of neoadjuvant chemoradiotherapy followed by surgery for locally advanced rectal cancer
by: Attila Paszt, et al.
Published: (2022-12-01)

CD11c+ and IRF8+ cell densities in rectal cancer biopsies predict outcomes of neoadjuvant chemoradiotherapy
by: Benita C. Y. Tse, et al.
Published: (2023-12-01)

Lipid metabolism-associated genes serve as potential predictive biomarkers in neoadjuvant chemoradiotherapy combined with immunotherapy in rectal cancer
by: Qiliang Peng, et al.
Published: (2024-01-01)

The Gut Microbiome Is Associated With Therapeutic Responses and Toxicities of Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients—A Pilot Study
by: Wei Shi, et al.
Published: (2020-12-01)

Predictive Factors of the Response of Rectal Cancer to Neoadjuvant Radiochemotherapy
by: Anita De Rossi, et al.
Published: (2011-04-01)

Use of patient‐derived tumor organoid platform to predict the benefit of postoperative adjuvant chemotherapy for poor responders to neoadjuvant chemoradiotherapy in locally advanced rectal cancer
by: Weisong Xue, et al.
Published: (2023-11-01)

Biomarkers of Favorable vs. Unfavorable Responses in Locally Advanced Rectal Cancer Patients Receiving Neoadjuvant Concurrent Chemoradiotherapy
by: Hsin-Hua Lee, et al.
Published: (2022-05-01)

Long-term outcomes of neoadjuvant-synchronous S-1 plus radiotherapy for locally advanced rectal cancer: a multi-institutional prospective phase II study
by: Takahiro Hiratsuka, et al.
Published: (2018-10-01)

Influencing factors and establishment of a prediction model for the tumor regression after neoadjuvant chemoradiotherapy in locally advanced rectal cancer
by: LIU Zhiyu, XU Dong, CHEN Xihao, LI Jipeng
Published: (2024-02-01)

Identification of proteomic markers for prediction of the response to 5-Fluorouracil based neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients
by: Jianan Wang, et al.
Published: (2022-03-01)

A novel LARCassigner3 classification predicts outcomes in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy: a retrospective training and validation analysis
by: Zhang J, et al.
Published: (2019-05-01)

Poor prognostic and staging value of tumor deposit in locally advanced rectal cancer with neoadjuvant chemoradiotherapy
by: Yaqi Wang, et al.
Published: (2019-04-01)

A Case with Rectal Cancer Relapses After Clinical Complete Remission Following Neoadjuvant Chemoradiotherapy
by: Zhang PB, et al.
Published: (2019-12-01)